Physical and functional interaction between wild-type p53 and mdm2 proteins

Molecular and Cellular Biology

Volumn 14, Issue 2, 1994, Pages 1171-1178

  Haines, Dale S ^a   Landers, John E ^a   Engle, Linda J ^a   George, Donna L ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEIN P53;

ARTICLE; CELL GROWTH; CELL ONCOGENE; CELL TRANSFORMATION; CONTROLLED STUDY; GENE ACTIVATION; GENE AMPLIFICATION; GENE CONTROL; GROWTH REGULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; REPORTER GENE; STRUCTURE ACTIVITY RELATION;

MAMMALIA; MURINAE;

EID: 0028147405     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.14.2.1171     Document Type: Article

References (45)

1. Baker, S. J., S. Markowitz, E. R. Fearon, J. K. V. Wilson, and B. Vogelstein. 1990. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912-915.
2. Barak, Y., and M. Oren. 1992. Enhanced binding of a 95 Kd protein to p53 in cells undergoing p53-mediated growth arrest. EMBO J. 11:2115-2121.
3. Cahilly-Snyder, L., T. Yang-Feng, U. Francke, and D. L. George. 1987. Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line. Somatic Cell Mol. Genet. 13:235-244.
4. Chen, J., V. Marechal, and A. J. Levine. 1993. Mapping of the p53 and mdm2 interaction domains. Mol. Cell. Biol. 13:4107-4114.
5. Chin, K. V., K. Ueda, I. Pastan, and M. M. Gottesman. 1992. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. Science 255:459-462.
6. Clarke, A. R., C. A. Purdie, D. J. Harrison, R. G. Morris, C. C. Bird, M. L. Hooper, and A. H. Wyllie. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (London) 362:849-852.
7. Dewit, J. R., K. V. Wood, M. Deluca, D. R. Helinski, and S. Subramani. 1987. Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol. 7:725-737.
8. Diller, L., J. Kassel, C. E. Nelson, M. A. Gryka, G. Litwak, M. Gebhardt, B. Bressac, M. Ozturk, S. J. Baker, B. Vogelstein, and S. H. Friend. 1990. p53 functions as a cell cycle control protein in osteosarcomas. Mol. Cell. Biol. 10:5772-5781.
9. El-Deiry, W. S., S. E. Kern, J. A. Pietenpol, and K. W. Kinzler. 1992. Definition of a consensus binding site for p53. Nature Genet. 1:45-49.
10. Eliyah, D., D. Michalovitz, S. Eliyahu, O. Pinhasi-Kima, and M. Oren. 1989. Wild-type p53 can inhibit oncogene-mediated focus formation. Proc. Natl. Acad. Sci. USA 86:8763-8767.
11. Farkharzadeh, S. S., S. P. Trusko, and D. L. George. 1991. Tumorigenic potential associated with enhanced expression of a gene that is amplified in mouse tumor cell line. EMBO J. 10:1565-1569.
12. Farmer, G. E., J. Bargonetti, H. Zhu, P. Friedman, R. Prywes, and C. Prives. 1992. Wild-type p53 activates transcription in vitro. Nature (London) 358:83-86.
13. Finlay, C. A. 1993. The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth. Mol. Cell. Biol. 13:301-306.
14. Finlay, C. A., P. W. Hinds, and A. J. Levine. 1989. The p53 proto-oncogene can act as a suppressor of transformation. Cell 57:1083-1093.
15. Funk, W. D., D. T. Pak, R. H. Karas, W. E. Wright, and J. W. Shay. 1992. Transcriptionally active DNA-binding site for human p53 protein complexes. Mol. Cell. Biol. 12:2866-2871.
16. George, D. L., and V. Powers. 1982. Amplified DNA sequences associated with double minutes of a 3T3 mouse cell line, p. 199-204. In R. Schimke (ed.), Gene amplification. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
17. Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044-1051.
18. Graham, F., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467.
19. Haines, D. S., and D. L. George. Unpublished data.
20. Hinds, P. W., C. A. Finlay, R. S. Quortin, S. J. Baker, E. R. Fearon, B. Vogelstein, and A. J. Levine. 1990. Mutant p53 cDNAs from human colorectal carcinomas can cooperate with ras in transformation of primary rat cells: a comparison of the "hot spot" mutant phenotypes. Cell Growth Differ. 1:571-580.
21. Hollstein, M., D. Sidransky, B. Vogelstein, and C. C. Harris. 1991. p53 mutations in human cancers. Science 253:49-53.
22. Kern, S., K. Kinzler, A. Bruskin, D. Jarosz, P. Friedman, C. Prives, and B. Vogelstein. 1991. Identification of p53 as a sequence-specific DNA binding protein. Science 252:1708-1711.
23. Kern, S. E., J. A. Pietenpol, S. Thiagalingam, A. Seymour, K. W. Kinzler, and B. Vogelstein. 1992. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256:827-830.
24. Landanyi, M., C. Cha, R. Lewis, S. C. Jhanwar, A. G. Huvos, and J. H. Healy. 1993. MDM2 gene amplification in metastatic osteosarcoma. Cancer Res. 53:16-18.
25. Levine, A. J., J. Momand, and C. A. Finlay. 1991. The p53 tumour suppressor gene. Nature (London) 351:453-455.
26. Livingston, L. R., A. White, J. Sprouse, E. Livanos, T. Jacks, and T. D. Tlsty. 1993. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70:923-935.
27. Lowe, S. W., H. E. Ruley, T. Jacks, and D. E. Housman. 1993. p53 dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957-967.
28. Lowe, S. W., E. M. Schmitt, S. W. Smith, B. A. Osborne, and T. Jacks. 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (London) 362:847-849.
29. Martinez, J., I. Georgoff, J. Martinez, and A. J. Levine. 1991. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev. 5:151-159.
30. Mercer, W. E., M. T. Shields, M. Amin, G. J. Sauve, E. Appelle, J. W. Romano, and S. J. Ullrich. 1990. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc. Natl. Acad. Sci. USA 87:6166-6170.
31. Momand, J., G. P. Zambetti, D. Olson, D. L. George, and A. J. Levine. 1992. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237-1245.
32. Oliner, J. D., K. W. Kinzler, P. S. Meltzer, D. L. George, and B. Vogelstein. 1992. Amplification of a gene ending a p53 associated protein in human sarcomas. Nature (London) 358:80-83.
33. Oliner, J. D., J. A. Pietenpol, S. Thiagalingam, J. Gyuris, K. W. Kinzler, and B. Vogelstein. 1993. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature (London) 362:857-860.
34. Olson, D. C., V. Marechal, J. Momand, J. Chen, C. Romocki, and A. J. Levine. 1993. Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes. Oncogene 8:2353-2360.
35. Otto, A., and W. Deppert. 1993. Upregulation of mdm-2 expression in meth a tumor cells tolerating wild-type p53. Oncogene 8:2591-2603.
36. Seto, E., A. Usheva, G. P. Zambetti, J. Momand, N. Horokoshi, R. Weinmann, A. J. Levine, and T. Shenk. 1992. Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc. Natl. Acad. Sci. USA 89:12028-12032.
37. Shaulsky, G., N. Goldfinger, A. Peled, and V. Rotter. 1991. Involvement of wild-type p53 in pre-B cell differentiation in vitro. Proc. Natl. Acad. Sci. USA 88:8982-8986.
38. Shaw, P., R. Bovey, S. Tardy, R. Sahli, B. Sordat, and J. Costa. 1992. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc. Natl. Acad. Sci. USA 89:4495-4499.
39. Subler, M. A., D. W. Martin, and S. Deb. 1992. Inhibition of viral and cellular promoters by human wild-type p53. J. Virol. 66:4757-1762.
40. Tan, T. H., J. Wallis, and A. J. Levine. 1986. Identification of the p53 protein domain involved in formation of the simian virus 40 large T-antigen-p53 protein complex. J. Virol. 59:574-583.
41. Vogelstein, B., and K. W. Kinzler. 1992. p53 function and dysfunction. Cell 70:523-526.
42. Wu, X., J. H. Bayle, D. Olson, and A. J. Levine. 1993. The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 7:1126-1132.
43. Yin, Y., M. A. Tainsky, F. Z. Bischoff, L. C. Strong, and G. M. Wahl. 1993. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70:937-948.
44. Yonish-Rouach, E., D. Resnitzky, J. Lotem, L. Sachs, A. Kimchi, and M. Oren. 1991. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (London) 352:345-347.
45. Zambetti, G. P., J. Bargonetti, K. Walker, C. Prives, and A. J. Levine. 1992. Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element. Genes Dev. 6:1143-1152.